IRONWOOD PHARMACEUTICALS, INC. Investing Cash Flow
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Investing Cash Flow of -$34.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-06
- IRONWOOD PHARMACEUTICALS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $1.00K.
- IRONWOOD PHARMACEUTICALS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$2.00K.
- IRONWOOD PHARMACEUTICALS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-06-30 was -$2.00K.
- IRONWOOD PHARMACEUTICALS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-03-31 was -$31.00K.
- IRONWOOD PHARMACEUTICALS, INC. net cash provided by (used in) investing activities for fiscal 2025 was -$34.00K.
- IRONWOOD PHARMACEUTICALS, INC. net cash provided by (used in) investing activities for fiscal 2024 was -$142.00K.
- IRONWOOD PHARMACEUTICALS, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$1.03B.
- IRONWOOD PHARMACEUTICALS, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$136.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.00K derived: sum of 2 quarters · filed 2026-02-26 | -$3.00K derived: sum of 3 quarters · filed 2026-08-06 | -$34.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$4.00K derived: sum of 2 quarters · filed 2026-08-06 | -$35.00K 10-Q · filed 2025-11-10 | -$35.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$33.00K 10-Q · filed 2026-08-06 | -$33.00K derived: sum of 3 quarters · filed 2026-08-06 | -$49.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$31.00K 10-Q · filed 2026-05-07 | -$31.00K derived: sum of 2 quarters · filed 2026-05-07 | -$47.00K derived: sum of 3 quarters · filed 2026-05-07 | -$105.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$16.00K derived: sum of 2 quarters · filed 2026-02-26 | -$74.00K derived: sum of 3 quarters · filed 2026-02-26 | -$142.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | -$16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$74.00K derived: sum of 2 quarters · filed 2025-11-10 | -$142.00K 10-Q · filed 2025-11-10 | -$4.33M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$126.00K 10-Q · filed 2025-08-11 | -$4.31M derived: sum of 3 quarters · filed 2025-08-11 | -$26.94M derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | -$68.00K 10-Q · filed 2025-05-12 | -$4.26M derived: sum of 2 quarters · filed 2025-05-12 | -$26.88M derived: sum of 3 quarters · filed 2025-05-12 | -$1.03B derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$4.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$26.81M derived: sum of 2 quarters · filed 2025-03-31 | -$1.03B derived: sum of 3 quarters · filed 2025-03-31 | -$1.03B 10-K · filed 2025-03-31 |
| 2023-09-30 | -$22.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.02B derived: sum of 2 quarters · filed 2024-11-07 | -$1.02B 10-Q · filed 2024-11-07 | -$1.02B derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-06-30 | -$999.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$999.50M 10-Q · filed 2024-08-08 | -$999.48M derived: sum of 3 quarters · filed 2025-03-31 | -$999.54M derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-03-31 | -$13.00K 10-Q · filed 2024-05-09 | $14.00K derived: sum of 2 quarters · filed 2025-03-31 | -$52.00K derived: sum of 3 quarters · filed 2025-03-31 | -$140.00K derived: sum of 4 quarters · filed 2025-03-31 |
| 2022-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$39.00K derived: sum of 2 quarters · filed 2025-03-31 | -$127.00K derived: sum of 3 quarters · filed 2025-03-31 | -$136.00K 10-K · filed 2025-03-31 |
| 2022-09-30 | -$66.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$154.00K derived: sum of 2 quarters · filed 2023-11-09 | -$163.00K 10-Q · filed 2023-11-09 | -$291.00K derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-06-30 | -$88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$97.00K 10-Q · filed 2023-08-09 | -$225.00K derived: sum of 3 quarters · filed 2024-02-16 | |
| 2022-03-31 | -$9.00K 10-Q · filed 2023-05-04 | -$137.00K derived: sum of 2 quarters · filed 2024-02-16 | ||
| 2021-12-31 | -$128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | -$265.00K 10-K · filed 2024-02-16 | ||
| 2021-09-30 | -$137.00K 10-Q · filed 2022-11-03 | |||
| 2020-12-31 | -$28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | -$28.00K derived: sum of 2 quarters · filed 2023-02-16 | -$404.00K derived: sum of 3 quarters · filed 2023-02-16 | -$1.84M 10-K · filed 2023-02-16 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$376.00K derived: sum of 2 quarters · filed 2021-11-04 | -$1.81M 10-Q · filed 2021-11-04 | -$4.47M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-06-30 | -$376.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$1.81M 10-Q · filed 2021-08-05 | -$4.47M derived: sum of 3 quarters · filed 2022-02-18 | -$7.55M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-31 | -$1.44M 10-Q · filed 2021-05-06 | -$4.10M derived: sum of 2 quarters · filed 2022-02-18 | -$7.18M derived: sum of 3 quarters · filed 2022-02-18 | -$9.61M derived: sum of 4 quarters · filed 2022-02-18 |
| 2019-12-31 | -$2.66M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | -$5.74M derived: sum of 2 quarters · filed 2022-02-18 | -$8.17M derived: sum of 3 quarters · filed 2022-02-18 | -$11.14M 10-K · filed 2022-02-18 |
| 2019-09-30 | -$3.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$5.51M derived: sum of 2 quarters · filed 2020-11-05 | -$8.48M 10-Q · filed 2020-11-05 | $9.01M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-06-30 | -$2.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$5.41M 10-Q · filed 2020-08-06 | $12.08M derived: sum of 3 quarters · filed 2021-02-17 | $26.37M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-03-31 | -$2.98M 10-Q · filed 2020-05-06 | $14.51M derived: sum of 2 quarters · filed 2021-02-17 | $28.80M derived: sum of 3 quarters · filed 2021-02-17 | $41.24M derived: sum of 4 quarters · filed 2021-02-17 |
| 2018-12-31 | $17.49M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $31.77M derived: sum of 2 quarters · filed 2021-02-17 | $44.21M derived: sum of 3 quarters · filed 2021-02-17 | $88.87M 10-K · filed 2021-02-17 |
| 2018-09-30 | $14.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $26.73M derived: sum of 2 quarters · filed 2019-10-31 | $71.38M 10-Q · filed 2019-10-31 | $37.52M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $12.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $57.09M 10-Q · filed 2019-07-30 | $23.24M derived: sum of 3 quarters · filed 2020-02-13 | $49.90M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $44.65M 10-Q · filed 2019-05-02 | $10.80M derived: sum of 2 quarters · filed 2020-02-13 | $37.46M derived: sum of 3 quarters · filed 2020-02-13 | $108.05M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | -$33.85M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | -$7.19M derived: sum of 2 quarters · filed 2020-02-13 | $63.40M derived: sum of 3 quarters · filed 2020-02-13 | $151.46M 10-K · filed 2020-02-13 |
| 2017-09-30 | $26.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $97.25M derived: sum of 2 quarters · filed 2018-11-06 | $185.31M 10-Q · filed 2018-11-06 | $69.89M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $70.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $158.65M 10-Q · filed 2018-08-06 | $43.23M derived: sum of 3 quarters · filed 2019-02-25 | -$47.13M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $88.06M 10-Q · filed 2018-05-04 | -$27.36M derived: sum of 2 quarters · filed 2019-02-25 | -$117.73M derived: sum of 3 quarters · filed 2019-02-25 | |
| 2016-12-31 | -$115.42M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | -$205.78M derived: sum of 2 quarters · filed 2019-02-25 | -$177.67M 10-K · filed 2019-02-25 | |
| 2016-09-30 | -$90.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$62.25M 10-Q · filed 2017-11-02 | ||
| 2016-06-30 | $28.11M 10-Q · filed 2017-08-03 | |||
| 2015-12-31 | -$9.15M 10-K · filed 2018-02-22 | |||
| 2015-03-31 | $19.76M 10-Q · filed 2015-05-06 | $58.07M derived: sum of 2 quarters · filed 2017-02-22 | $50.19M derived: sum of 3 quarters · filed 2017-02-22 | -$30.34M derived: sum of 4 quarters · filed 2017-02-22 |
| 2014-12-31 | $38.31M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $30.43M derived: sum of 2 quarters · filed 2017-02-22 | -$50.10M derived: sum of 3 quarters · filed 2017-02-22 | -$56.57M 10-K · filed 2017-02-22 |
| 2014-09-30 | -$7.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | -$88.41M derived: sum of 2 quarters · filed 2014-11-05 | -$94.88M 10-Q · filed 2014-11-05 | -$122.96M derived: sum of 4 quarters · filed 2015-05-06 |
| 2014-06-30 | -$80.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | -$87.00M 10-Q · filed 2014-08-05 | -$115.08M derived: sum of 3 quarters · filed 2015-05-06 | -$133.10M derived: sum of 4 quarters · filed 2015-05-06 |
| 2014-03-31 | -$6.47M 10-Q · filed 2015-05-06 | -$34.55M derived: sum of 2 quarters · filed 2015-05-06 | -$52.57M derived: sum of 3 quarters · filed 2015-05-06 | $610.00K derived: sum of 4 quarters · filed 2015-05-06 |
| 2013-12-31 | -$28.08M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | -$46.10M derived: sum of 2 quarters · filed 2015-02-18 | $7.08M derived: sum of 3 quarters · filed 2015-02-18 | -$101.43M 10-K · filed 2015-02-18 |
| 2013-09-30 | -$18.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $35.16M derived: sum of 2 quarters · filed 2014-11-05 | -$73.35M 10-Q · filed 2014-11-05 | -$41.13M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-06-30 | $53.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | -$55.33M 10-Q · filed 2014-08-05 | -$23.11M derived: sum of 3 quarters · filed 2015-02-18 | -$23.79M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-03-31 | -$108.52M 10-Q · filed 2014-04-29 | -$76.29M derived: sum of 2 quarters · filed 2015-02-18 | -$76.97M derived: sum of 3 quarters · filed 2015-02-18 | -$79.72M derived: sum of 4 quarters · filed 2015-02-18 |
| 2012-12-31 | $32.23M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $31.55M derived: sum of 2 quarters · filed 2015-02-18 | $28.79M derived: sum of 3 quarters · filed 2015-02-18 | $30.08M 10-K · filed 2015-02-18 |
| 2012-09-30 | -$680.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | -$3.44M derived: sum of 2 quarters · filed 2013-10-28 | -$2.15M 10-Q · filed 2013-10-28 | $23.40M derived: sum of 4 quarters · filed 2014-02-07 |
| 2012-06-30 | -$2.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$1.47M 10-Q · filed 2013-08-08 | $24.08M derived: sum of 3 quarters · filed 2014-02-07 | $69.56M derived: sum of 4 quarters · filed 2014-02-07 |
| 2012-03-31 | $1.29M 10-Q · filed 2013-04-23 | $26.83M derived: sum of 2 quarters · filed 2014-02-07 | $72.32M derived: sum of 3 quarters · filed 2014-02-07 | |
| 2011-12-31 | $25.54M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-07 | $71.03M derived: sum of 2 quarters · filed 2014-02-07 | $115.06M 10-K · filed 2014-02-07 | |
| 2011-09-30 | $45.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $89.52M 10-Q · filed 2011-11-09 | ||
| 2011-06-30 | $44.04M 10-Q · filed 2011-08-12 | |||
| 2010-12-31 | -$14.47M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $32.23M derived: sum of 2 quarters · filed 2013-02-21 | -$213.04M 10-K · filed 2013-02-21 | |
| 2010-09-30 | $46.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | -$198.57M 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | -$245.27M 10-Q · filed 2011-08-12 | |||
| 2009-12-31 | $17.76M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |